A previous report demonstrated that the HDACi romidepsin enhances response to PD-1 blockade in lung cancer by inducing the expression of CCL5, CXCL9 and CXCL10, and thus enhancing T cells infiltration [20]. This evidence concerns the gene CCL5 and lung carcinoma.